Entinostat in combination with nivolumab for patients with advanced cholangiocarcinoma: a phase 2 clinical trial
Abstract Introduction Cholangiocarcinoma (CCA) is an aggressive cancer characterized by high metastatic potential and poor prognosis. Recent advances in understanding the molecular biology of CCA have led to the development of novel therapeutic strategies. However, the immunosuppressive tumor microe...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2025-07-01
|
| Col·lecció: | Epigenetics Communications |
| Accés en línia: | https://doi.org/10.1186/s43682-025-00037-z |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|